Digital Pathology Market valued at USD 6.19 Billion in 2021 and is expected to witness a CAGR of 13.5% during the forecast period 2021 – 2031

The digital pathology market has witnessed notable changes in terms of product innovation. One of the major reasons behind this is the scope of cloud integration with pathology outcomes in laboratory operations. According to a recent report by Future Market Insights, the global digital pathology market was valued at USD 6.19 Bn in 2021 and is expected to witness a CAGR of 13.5% during the forecast period (2021 – 2031).

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/Global-digital-pathology-market

The scope of digital pathology with cloud integration has expanded with promising potential for numerous therapies in the healthcare industry including anti-cancer treatments. Innovation in terms of product efficiency, capabilities, and other modalities drives growth in the digital pathology market.

A number of modern hospitals are installing newly modified digital pathology systems for their laboratories which has widened the consumer base of the market globally. Manufacturers of digital pathology solutions are constantly making changes in software, to enhance the capabilities and efficacies of digital pathology devices.

This development will provide easy access to information such as images, and will also cater to specialized needs. In 2017, Glencoe Software Inc., launched a software named Path Viewer, which is used in interactive viewing and annotation of digital pathology images.

In Jan 2018, Definiens AG released Tissue Studio 4.2 software package. The updated product suite provided improved image analysis for researchers in academic medical laboratories, comprehensive cancer diagnostic and treatment centers, biotechnology, and pharmaceutical companies.

To remain ‘ahead’ of your competitors, request for a sample https://www.futuremarketinsights.com/reports/sample/rep-gb-124

Key Points Covered in Digital Pathology Market Study

Market estimates and forecast 2016-2031
Key drivers and restraints impacting Digital Pathology Market growth
Segment-wise analysis, Country-wise, and Region-wise Analysis
Competition Mapping and Benchmarking
Key Product Innovations and Regulatory Climate
COVID-19 Impact on Digital Pathology and How to Navigate
Recommendation on Key Winning Strategies

Key Players:

Danaher Corporation
F. Hoffmann-La Roche AG
Huron Technologies International Inc.
Koninklijke Philips N.V.
Olympus Corporation
Hamamatsu Photonics K.K.
Carl Zeiss AG
Nikon Corporation
3DHISTECH Ltd.
Hologic Inc.
PerkinElmer, Inc.
Visiopharm
OptraSCAN, Inc.
Inspirata, Inc.
Sectra AB.

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-124

Key Takeaways of Digital Pathology Market Study

Digital pathology equipment is anticipated to increase at a CAGR of 13.7% over 2021-2031, to reach US$ 12.94 Bn by 2031, aided by growing investments by hospitals and laboratories.
The clinical pathology and molecular diagnostics segment collectively have gained more than 50% of the market share in terms of revenue owing to use for a wider scope of ailments.
CROs are estimated to display high growth potential at a CAGR of 19.0% in the forecast period owing to cost benefits to end users.
Canada is reflecting high potential for growth with a 14.2% CAGR, driven by the expansion of urban centers and investments into healthcare facilities.
The U.K. will account for over 24% of the Europe value share, surpassing Germany by 2031, owing to increases in healthcare research spending.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-124

key segment

By Product Type:

Equipment
Whole Slide Scanners
Brightfield Slide Scanners
Fluorescence Slide Scanners
Combination Slide Scanners
Clinical Microscope
Tissue Microarrays
Softwares
Image Viewing and Analysis Softwares
On-premise
Cloud-based
Digital Pathology Information Systems
On-premise
Cloud-based
Services
Installation and Integration Services
Consulting Services
Maintenance and Validation Services

By Application:

Clinical Patholog
Molecular Diagnostics
Basic & Applied Research
Drug Development
Others

End-User:

Hospitals
Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Forensic Laboratories
Research Institutes
Contract Research Organizations (CROs)
Clinics

Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
The Middle East and Africa (MEA)

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.